60 degrees pharmaceuticals to participate in h.c. wainwright 25th annual global investment conference

Washington, sept. 06, 2023 (globe newswire) -- 60 degrees pharmaceuticals inc. (“60p” or the “company”) (nasdaq: sxtp ), a pharmaceutical company focused on developing new medicines for infectious diseases, announced today that ceo dr. geoff dow and cfo ty miller will participate in the h.c. wainwright 25th annual global investment conference  september 11-13, to be held in new york city.
SXTP Ratings Summary
SXTP Quant Ranking